These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 34368386)

  • 1. Drug-Induced Liver Injury From Enobosarm (Ostarine), a Selective Androgen Receptor Modulator.
    Bedi H; Hammond C; Sanders D; Yang HM; Yoshida EM
    ACG Case Rep J; 2021 Jan; 8(1):e00518. PubMed ID: 34368386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-Induced Liver Injury Secondary to Enobosarm: A Selective Androgen Receptor Modulator.
    Weinblatt D; Roy S
    J Med Cases; 2022 May; 13(5):244-248. PubMed ID: 35655632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of ostarine (enobosarm/GTX024), a selective androgen receptor modulator, on adipocyte metabolism in Wistar rats.
    Leciejewska N; Pruszynska-Oszmalek E; Bien J; Nogowski L; Kolodziejski PA
    J Physiol Pharmacol; 2019 Aug; 70(4):. PubMed ID: 31642815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver injury associated with the use of selective androgen receptor modulators and post-cycle therapy: Two case reports and literature review.
    Koller T; Vrbova P; Meciarova I; Molcan P; Smitka M; Adamcova Selcanova S; Skladany L
    World J Clin Cases; 2021 Jun; 9(16):4062-4071. PubMed ID: 34141767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective androgen receptor modulators for the prevention and treatment of muscle wasting associated with cancer.
    Dalton JT; Taylor RP; Mohler ML; Steiner MS
    Curr Opin Support Palliat Care; 2013 Dec; 7(4):345-51. PubMed ID: 24189892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Considerations, possible contraindications, and potential mechanisms for deleterious effect in recreational and athletic use of selective androgen receptor modulators (SARMs) in lieu of anabolic androgenic steroids: A narrative review.
    Machek SB; Cardaci TD; Wilburn DT; Willoughby DS
    Steroids; 2020 Dec; 164():108753. PubMed ID: 33148520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective Androgen Receptor Modulators: An Emerging Liver Toxin.
    Mohideen H; Hussain H; Dahiya DS; Wehbe H
    J Clin Transl Hepatol; 2023 Feb; 11(1):188-196. PubMed ID: 36479151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ostarine-Induced Myogenic Differentiation in C2C12, L6, and Rat Muscles.
    Leciejewska N; Kołodziejski PA; Sassek M; Nogowski L; Małek E; Pruszyńska-Oszmałek E
    Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective Androgen Receptor Modulator Induced Hepatotoxicity.
    Khan S; Fackler J; Gilani A; Murphy S; Polintan L
    Cureus; 2022 Feb; 14(2):e22239. PubMed ID: 35340496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RAD-140 Drug-Induced Liver Injury.
    Leung K; Yaramada P; Goyal P; Cai CX; Thung I; Hammami MB
    Ochsner J; 2022; 22(4):361-365. PubMed ID: 36561105
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of ostarine as a selective androgen receptor modulator in a rat model of postmenopausal osteoporosis.
    Hoffmann DB; Komrakova M; Pflug S; von Oertzen M; Saul D; Weiser L; Walde TA; Wassmann M; Schilling AF; Lehmann W; Sehmisch S
    J Bone Miner Metab; 2019 Mar; 37(2):243-255. PubMed ID: 29785666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective Androgen Receptor Modulator-Induced Liver Injury in Active Duty Male.
    Lee BK; Park BB; Bower RJ
    Mil Med; 2022 Mar; ():. PubMed ID: 35253885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study Design and Rationale for the Phase 3 Clinical Development Program of Enobosarm, a Selective Androgen Receptor Modulator, for the Prevention and Treatment of Muscle Wasting in Cancer Patients (POWER Trials).
    Crawford J; Prado CM; Johnston MA; Gralla RJ; Taylor RP; Hancock ML; Dalton JT
    Curr Oncol Rep; 2016 Jun; 18(6):37. PubMed ID: 27138015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective androgen receptor modulators (SARMs) have specific impacts on the mouse uterus.
    Simitsidellis I; Esnal-Zuffiaure A; Kelepouri O; O'Flaherty E; Gibson DA; Saunders PTK
    J Endocrinol; 2019 Sep; 242(3):227-239. PubMed ID: 31319382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective Androgen Receptor Modulators (SARMs)-Induced Liver Injury: A Case Report and Review of Literature.
    Mohamed WT; Jahagirdar V; Fatima I; Ahmed MK; Jaber F; Wang K; Hassan A; Ewing E; Clarkston W; Likhitsup A
    Cureus; 2023 Feb; 15(2):e35094. PubMed ID: 36945289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Selective Androgen Receptor Modulator Ostarine Improves Bone Healing in Ovariectomized Rats.
    Komrakova M; Furtwängler J; Hoffmann DB; Lehmann W; Schilling AF; Sehmisch S
    Calcif Tissue Int; 2020 Feb; 106(2):147-157. PubMed ID: 31531719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective androgen receptor modulators: the future of androgen therapy?
    Christiansen AR; Lipshultz LI; Hotaling JM; Pastuszak AW
    Transl Androl Urol; 2020 Mar; 9(Suppl 2):S135-S148. PubMed ID: 32257854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the growing public interest in selective androgen receptor modulators.
    Efimenko IV; Chertman W; Masterson TA; Dubin JM; Ramasamy R
    Andrologia; 2021 Dec; 53(11):e14238. PubMed ID: 34510504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective Androgen Receptor Modulators: Current Knowledge and Clinical Applications.
    Solomon ZJ; Mirabal JR; Mazur DJ; Kohn TP; Lipshultz LI; Pastuszak AW
    Sex Med Rev; 2019 Jan; 7(1):84-94. PubMed ID: 30503797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of SARMs in doping control analysis.
    Thevis M; Schänzer W
    Mol Cell Endocrinol; 2018 Mar; 464():34-45. PubMed ID: 28137616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.